2,971
Participants
Start Date
February 28, 2002
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
Infliximab (Remicade)
This is an non-interventional study. Participants took the study product as part of their medical routine.
Birmingham
Huntsville
Montgomery
Paradise Valley
Phoenix
Tucson
Little Rock
Anaheim
Fresno
Irvine
Los Angeles
Madera
Orange
Pasadena
Rancho Mirage
San Diego
Santa Monica
Stanford
Torrance
Denver
Hamden
Hartford
New Haven
Waterbury
Aventura
Largo
Ocala
Orlando
Palm Harbor
Sarasota
Tampa
Alpharetta
Atlanta
Marietta
Coeur d'Alene
Chicago
Evanston
Gurnee
Maywood
Normal
Rockford
Springfield
Indianapolis
Iowa City
Overland Park
Wichita
Louisville
Portland
Baltimore
Greenbelt
Wheaton
Andover
Boston
Worcester
Ann Arbor
Detroti
East Lansing
Grand Rapids
Edina
Fridley
Jackson
St Louis
Lincoln
Reno
Voorhees Township
Manhasset
New York
Rochester
Charlotte
Durham
Raleigh
Wilmington
Winston-Salem
Akron
Cincinnati
Cleveland
Columbus
Oklahoma City
Lake Oswego
Portland
Bethlehem
Lancaster
Norristown
Philadelphia Pennsylvan
West Reading
Willow Grove
North Charleston
Goodlettsville
Nashville
Dallas
Houston
Lubbock
San Antonio
Burlington
Salem
Bellevue
Kirkland
Seattle
Spokane
Milwaukee
Buenos Aires
Córdoba
Cp
Rosario
San Miguel de Tucumán
Graz
Innsbruck
Vienna
Brussels
Diepenbeek
Edegem
Genk
Ghent
Leuven
Liège
Calgary
Edmonton
Richmond
Vancouver
Winnipeg
Moncton
St. John's
Halifax
Hamilton
Kitchener
London
Markham
Newmarket
North Bay
Ottawa
Toronto
Waterloo
Montreal
Québec
Sainte-Foy
Sherbrooke
Ste-Foy
Halifax
Hamilton Ontario
Montreal
Saskatoon
Aarhus
Hellerup
Hvidovre
København NV
Odense
Helsinki
Hus
Jyväskylä
Pikonlinna
Créteil
Montpellier
Nantes
Nice
Paris
Pierre-Bénite
Poitiers
Berlin
Bochum
Cologne
Dresden
Erlangen
Frankfurt
Hamburg
Leipzig
Mainz
Münster
Oldenburg
Würzburg
Wÿrzburg
Budapest
Debrecen
Dublin
Haifa
Tel Aviv
Amsterdam-Zuidoost
Maastricht
Rotterdam
Utrecht
Oslo
Bialystok
Lublin
Szczecin
Warsaw
Wroclaw
Włoszczowa
Barcelona
Buenos Aires
Córdoba
Federal
Madrid
Gothenburg
Geneva
Zurich
Bath
Birmingham
Cambridge
Cannock
Leeds
Liverpool
London
Manchester
Newcastle upon Tyne
Norwich
Oxford
Lead Sponsor
Collaborators (1)
Centocor BV
INDUSTRY
Centocor, Inc.
INDUSTRY